Indonesia’s economy was expected to grow by 5.5% this 2016 fiscal year when it was first published. However, it is reduced to 5.2% just a few weeks ago. The reasons are various but the most important factor is the price of some exporting commodities, mineral oils, etc. that makes the government income from taxes and the like is lower than planned.
To overcome the deficit the government just launched a law called “Tax Amnesty”. The main aims are returning back abroad “paper-investment” home, and a realistic capital statement from middle class up to wealthy society. The penalty varies from 0.5% to 8% depending on the amount, type, and time.
A fraud arising from some vaccine counterfeit exploded by the end of June. Some 14 – 15 kinds of vaccine mostly imported ones were fake. The government through the Ministry of Health, the Police, and the BPOM (local FDA) has taken appropriate actions to overcome.
Indonesia has got a government owned pharmaceutical-company producing various kinds of vaccine and serum. The products are said to fulfill the local demand as well as exported to at least 130 foreign countries. Apparently, some people choose imported vaccines for their offspring.
A supply shortage of some infusion solutions is said to happen lately, due to the GMP surveillance audit taken recently to one of the leading manufacturers.
A BPOM (local FDA) regulation no. 17 / 2016 was issued and immediately enacted on 4th August 2016. This is to succeed regulation no. HK.03.1.23.10.11.0841/2011 on the criterion and route of drug registration.
In principle it announces the following routes of registration.
● Day = working day, 5 days in a week.
Jakarta 31st August 2016.